GeneDx Holdings (WGS) Non Operating Income (2020 - 2026)

GeneDx Holdings (WGS) has 7 years of Non Operating Income data on file, last reported at -$4.9 million in Q1 2026.

• Non Operating Income for Q1 2026 came in at -$4.9 million, down 223.19% year-over-year; the trailing twelve-month figure through Mar 2026 was -$15.8 million (up 20.46% YoY), and the FY2025 annual result was -$8.1 million, up 38.07% from the prior year.
• Non Operating Income climbed to -$4.9 million in Q1 2026 per WGS's latest filing, from -$8.3 million in the prior quarter.
• Over five years, Non Operating Income peaked at $27.8 million in Q2 2022 and troughed at -$18.8 million in Q2 2024.
• A 5-year average of $594125.0 and a median of -$269500.0 in 2022 frame the typical range for Non Operating Income.
• The sharpest annual moves came in 2022 and 2023: Non Operating Income jumped 4003.23% in 2022, then tumbled 56800.0% in 2023.
• A 5-year view of Non Operating Income shows it stood at $16.2 million in 2022, then tumbled by 103.34% to -$541000.0 in 2023, then slumped by 31.98% to -$714000.0 in 2024, then plunged by 1067.23% to -$8.3 million in 2025, then soared by 40.63% to -$4.9 million in 2026.
• Business Quant data shows WGS's Non Operating Income at -$4.9 million in Q1 2026, -$8.3 million in Q4 2025, and -$4.1 million in Q3 2025.